h. pylori

Rabeprazole Sulfide (Rabeprazole Related Compound E) 是 Rabeprazole 的活性代谢产物。Rabeprazole 是一种质子泵抑制剂类的抗溃疡药物，有效抑制幽门螺旋杆菌的活性，可通过与胃壁细胞中的(H+ K+)-ATPase 相互作用来抑制胃酸分泌，可研究各种消化系统疾病。

Xinjiachalcone A is a natural product isolated from Glycyrrhiza inflata Batalin. Xinjiachalcone A shows both a low MIC and a strong bactericidal activity against H. pylori(MIC : 12.5 to 50 µM, seventeen H. pylori strains).

Rebamipide (OPC12759) 是一种粘膜保护剂，可诱导COX-2表达，增加PGE2水平，并以 COX-2 依赖性方式增强胃粘膜防御。

Octyl gallate (Octyl 3,4,5-trihydroxybenzoate) 具有抗菌、抗氧化作用，有选择性和敏感性的荧光特性，广泛用作食品添加剂。它对 HSV-1，水泡性口炎病毒和脊髓灰质炎病毒有显著的抗病毒作用。

pNNP (Nitrophenylphosphate) 可用作 PP2C 试验的底物。pNNP 对β-碳酸酐酶和α-碳酸酯脱水酶有抑制作用，对幽门螺杆菌幽门螺杆菌也具有抑制作用。pNNP 是一种活性较弱的组织非特异性碱性磷酸酶调节剂。

4-Hexen-3-one 对 ATCC 43526 菌株和 TDR 菌株的 H. pylori 生长展示了明显的抑制作用，并抑制了尿素酶的活性。

VPC162134 是一种抗菌剂，能够抑制H. pylori、C. jejuni、MRSA和S. epidermidis，最低抑制浓度（MIC）分别为2.9、17.5、93.3和93.3 μM。此外，VPC162134 是丙酮酸铁氧还蛋白氧化还原酶 (PFOR) 的抑制剂。

JAK05 对 Helicobacter pylori 具有抑制活性，能抑制 J63、J196 和 J107 菌株，其最低抑制浓度（MIC）为 3-5 µg mL。JAK05 对 H+ K+-ATPase、COX-1 2、TNF-α 和 PGE2 具有结合亲和力，具备抗氧化及抗炎特性。该化合物在大鼠乙醇诱发的胃溃疡模型中显示出抗溃疡活性。

BAS-118 是一种具有抗菌活性的苯酰胺衍生物。在对 100 株随机选择的幽门螺杆菌(Helicobacter pylori) 分离株的测试中，其MIC50、MIC90和MIC范围分别为 ≤0.003、0.013 和 ≤0.003-0.025 mg L。BAS-118 有潜力用于抗H. pylori剂的研究。

Urease-IN-20 (compound XBP2) 是一种针对 Helicobacter pylori (H. pylori) 的抑制剂，具有 0.14 μM 的 IC50。在感染 H. pylori 的 GES-1 细胞中，Urease-IN-20 能减少细胞凋亡 (Apoptosis) 和降低 ROS 与 γH2AX 的水平。它展示了显著的胃黏膜保护作用，适用于幽门螺杆菌研究。

FR-193879 is an efficacious cephem derivative, it has extremely potent therapeutic efficacy against H. pylori.

Actinopyrone A is a pyrone isolated from S. pactum with diverse biological activities. It has selective and potent antimicrobial activity against H. pylori (MIC = 0.1 ng mL) with no activity against other Gram-negative bacteria including E. coli, K. pneumoniae, P. aeruginosa, and B. fragilis. Actinopyrone A also mildly inhibits growth of Gram-positive bacteria and dermatophytes with MIC values ranging from <6.25 to 25 μg mL. Intravenous administration of actinopyrone A (30 μg kg) increases coronary blood flow in dogs by 196.2%.

cis-9,10-Methyleneoctadecanoic acid is a cyclopropane fatty acid that has been found in bacteria and the digestive gland of P. globosa. It is a component of S. aureus cell membranes and levels decrease upon treatment with carvacrol. cis-9,10-Methyleneoctadecanoic acid is secreted by H. pylori and enhances histamine- and dibutyryl cAMP-stimulated acid secretion in isolated guinea pig parietal cells. It also activates protein kinase C (PKC) in a calcium-dependent manner.

Zonisamide-13C2,15N is intended for use as an internal standard for the quantification of zonisamide by GC- or LC-MS. Zonisamide is an antiepileptic agent.1 It selectively inhibits the repeated firing of sodium channels (IC50 = 2 μg ml) in mouse embryo spinal cord neurons and inhibits spontaneous channel firing when used at concentrations greater than 10 μg ml.2 In rat cerebral cortex neurons, zonisamide (1-1,000 μM) inhibits T-type calcium channels with a maximum reduction of 60% of the calcium current.3 Zonisamide inhibits H. pylori recombinant carbonic anhydrase (CA) and the human CA isoforms I, II, and V with Ki values of 218, 56, 35, and 21 nM, respectively.4,5 In mice, it has anticonvulsant activity against maximal electroshock seizure (MES) and pentylenetetrazole-induced maximal, but not minimal, seizures (ED50s = 19.6, 9.3, and >500 mg kg, respectively). Zonisamide (40 mg kg, p.o.) prevents MPTP-induced decreases in the levels of dopamine , but not homovanillic acid or dihydroxyphenyl acetic acid , and increases MPTP-induced decreases in the dopamine turnover rate in mouse striatum in a model of Parkinson's disease.6 Formulations containing zonisamide have been used in the treatment of partial seizures in adults with epilepsy. |1. Masuda, Y., Ishizaki, M., and Shimizu, M. Zonisamide: Pharmacology and clinical efficacy in epilepsy. CNS Drug Rev. 4(4), 341-360 (1998).|2. Rock, D.M., Macdonald, R.L., and Taylor, C.P. Blockade of sustained repetitive action potentials in cultured spinal cord neurons by zonisamide (AD 810, CI 912), a novel anticonvulsant. Epilepsy Res. 3(2), 138-143 (1989).|3. Suzuki, S., Kawakami, K., Nishimura, S., et al. Zonisamide blocks T-type calcium channel in cultured neurons of rat cerebral cortex. Epilepsy Res. 12(1), 21-27 (1992).|4. Nishimori, I., Vullo, D., Minakuchi, T., et al. Carbonic anhydrase inhibitors: Cloning and sulfonamide inhibition studies of a carboxyterminal truncated α-carbonic anhydrase from Helicobacter pylori. Bioorg. Med. Chem. Lett. 16(8), 2182-2188 (2006).|5. De Simone, G., Di Fiore, A., Menchise, V., et al. Carbonic anhydrase inhibitors. Zonisamide is an effective inhibitor of the cytosolic isozyme II and mitochondrial isozyme V: Solution and X-ray crystallographic studies. Bioorg. Med. Chem. Lett. 15(9), 2315-2320 (2005).|6. Yabe, H., Choudhury, M.E., Kubo, M., et al. Zonisamide increases dopamine turnover in the striatum of mice and common marmosets treated with MPTP. J. Pharmacol. Sci. 110(1), 64-68 (2009).

Vonoprazan hydrochloride 是一种高效且具口服活性的质子泵抑制剂 (PPI) 和钾竞争性酸阻断剂 (potassium-competitive acid blocker, P-CAB)，展示出优秀的抗分泌活性。在 pH 为 6.5 的条件下，该化合物可抑制猪胃微粒体内 H+,K+-ATPase 的酶活性，呈现出 19 nM 的 IC50 值。Vonoprazan hydrochloride 主要应用于胃酸相关疾病的研究，包括胃食管反流病和消化性溃疡，并可用于根除幽门螺杆菌。

8-Gingerol 分离自姜的根状茎，是口服有效的 TRPV1激活剂，EC50值为5.0 µM。8-Gingerol 抑制 COX-2，还能抑制体外 H. pylori 的生长。

Antibacterialagent 233(Compound 7c)在多方面展示了显著的抗菌和抗肿瘤特性.首先,该化合物对Helicobacter pylori有明显的抑制效果,其MIC值介于0.4-1.6 μg mL.此外,Antibacterialagent 233能有效抑制刀豆脲酶(jack bean urease),IC50值为0.27 μg mL,并能改变H. pylori的细胞膜通透性,导致细胞内容物的渗漏.在体外环境中,该化合物在全血和人工胃液中显示出良好的代谢稳定性.在生物医学研究中,Antibacterialagent 233还在小鼠体内展现对U2OS肿瘤细胞的抑制活性.

6,8-Diprenylorobol possesses weaker anti-H. pylori activity, it may be a useful chemopreventive agent for peptic ulcer or gastric cancer in H. pylori-infected individuals.

22-Dehydroclerosterol has antibacterial activity against against E. coli, S. aureus, and H. pylori.

9-Hydroxy-alpha-lapachone can highly inhibit the growth of H. pylori, it exhibits potent inhibitory activity against H. pylori Cystathionine gamma-synthase, with IC(50) values of 4.64 microM. It may have anti-inflammatory activity, it exhibits potent inhi

Dihydrolicoisoflavone A possesses weaker anti-H. pylori activity, it may be useful chemopreventive agents for peptic ulcer or gastric cancer in H. pylori-infected individuals.

Isojacareubin displays potent activity against H. pylori HP40 clinical isolate with MIC 23.9 uM, which is approximately two times greater than that of the standard drug amoxicillin. Isojacareubin is a potent inhibitor of protein kinase C (PKC), suppresses

α-1,4-N-Acetylglucosaminyltransferase 4 (EC 2.4.1, A4GNT) 催化N-乙酰葡糖胺 (GlcNAc) 的转移至核心2支链O-聚糖，并抑制幽门螺杆菌H. pylori的生长。